Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relationship of bypassed limb length and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass.

× No keyword cloud information.

8 in total

1. PRELIMINARY ANALYSIS OF INTERLEUKIN-6 CHANGES IN PRE- AND POSTOPERATIVE IN DIABETIC PATIENTS WITH BMI<35 SUBMITTED TO PARTIAL DUODENAL SWITCH.

Authors: Luciano Dias de Oliveira Reis; Paulo Afonso Nunes Nassif; Fernando Issamu Tabushi; Fábio Quirillo Milléo; Giovani Marino Favero; Bruno Luiz Ariede; Cassiana Franco Dias Dos Reis; Bruno Franco Dalabona
Journal: Arq Bras Cir Dig Date: 2016 Nov-Dec

2. Limb Length in Gastric Bypass in Super-Obese Patients-Importance of Length of Total Alimentary Small Bowel Tract.

Authors: Kamran Shah; Bent Johnny Nergård; Morten Wang Fagerland; Hjörtur Gislason
Journal: Obes Surg Date: 2019-07 Impact factor: 4.129

3. Customization of biliopancreatic limb length to modulate and sustain antidiabetic effect of gastric bypass surgery.

Authors: A Pal; D B Rhoads; A Tavakkoli
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-11-02 Impact factor: 4.052

4. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.

Authors: Chih Kun Huang; Chi-Ming Tai; Po-Chih Chang; Kirubakaran Malapan; Ching-Chung Tsai; Kamthorn Yolsuriyanwong
Journal: Obes Surg Date: 2016-10 Impact factor: 4.129

8. Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery.

Authors: Tae-Hoon Lee; Chang Min Lee; Sungsoo Park; Do Hyun Jung; You Jin Jang; Jong-Han Kim; Seong-Heum Park; Young-Jae Mok
Journal: J Gastric Cancer Date: 2017-11-15 Impact factor: 3.720

8 in total

Relationship of bypassed limb length and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass.

1. PRELIMINARY ANALYSIS OF INTERLEUKIN-6 CHANGES IN PRE- AND POSTOPERATIVE IN DIABETIC PATIENTS WITH BMI<35 SUBMITTED TO PARTIAL DUODENAL SWITCH.

2. Limb Length in Gastric Bypass in Super-Obese Patients-Importance of Length of Total Alimentary Small Bowel Tract.

3. Customization of biliopancreatic limb length to modulate and sustain antidiabetic effect of gastric bypass surgery.

4. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.

5. Repeated stretched or non-stretched small bowel length measurements in healthy individuals.

6. Short versus long biliopancreatic limb in Roux-en-Y gastric bypass surgery for treatment of type 2 diabetes mellitus.

7. Roux-en-Y gastric bypass: limb length and weight loss.

8. Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery.